An interventional study to assess patient-reported outcome measures in bradalumab treated patients with moderate to severe plaque psoriasis in Japa
Not Applicable
- Conditions
- psoriasis
- Registration Number
- JPRN-UMIN000027783
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 74
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with psoriatic erythroderma, pustular psoriasis and guttate psoriasis at the time of informed concent. 2)Patients with a severe infection or active tuberculosis at the time of informed concent. 3)Patients who are judged by the investigator or subinvestigator to be unsuitable for participation in this study. 4)Patients with joint symptoms at enrollment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method